On Thursday, Oct. 25, Celgene CELG will release its latest earnings report. Here is Benzinga's outlook for the company.
Earnings and Revenue
Celgene EPS will likely be near $2.23 while revenue will be around $3.84 billion, according to analysts.
Celgene EPS in the same period a year ago totaled $1.91. Sales were $3.29 billion. If the company were to match the consensus estimate when it reports Thursday, earnings would be up 16.75 percent. Revenue would be have grown 16.82 percent from the same quarter last year. Here's how the company's reported EPS has stacked up against analyst estimates in the past:
Quarter | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 |
EPS Estimate | 2.1 | 1.96 | 1.92 | 1.88 |
EPS Actual | 2.16 | 2.05 | 2 | 1.91 |
Stock Performance
Over the past 52-week period, shares of Celgene have declined 34.25 percent. Over the past 90 days, analysts' have generally adjusted their estimates higher for EPS and revenues. Analysts generally rate Celgene stock as Neutral. The strength of this rating has maintained conviction over the past three months.
Conference Call
Celgene's Q3 conference call is scheduled to begin at 9:00 a.m. ET and can be accessed here: https://edge.media-server.com/m6/p/h7uv35rz
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.